ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,47
0,34%
Bitcoin
60 887,58
-1,49%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Starpharma Holdings Adr (QX) (SPHRY)

  7. Starpharma Holdings Adr (QX) (SPHRY) Actualités

SPHRY

Starpharma Holdings Adr (QX) (SPHRY)

Starpharma Holdings Adr (QX)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:SPHRY
DateHeureSourceTitreSymboleSociété
15/09/201521h59Dow Jones NewsAustralia Looks to Health Care as Remedy for Resource-Slump DoldrumsUSOTC:SPHRYStarpharma Holdings Adr (QX)
24/10/201303h07OTC MarketsStarpharma Dendrimer-Docetaxel eliminates neutropeniaUSOTC:SPHRYStarpharma Holdings Adr (QX)
17/10/201306h04OTC MarketsNotice of Annual General MeetingUSOTC:SPHRYStarpharma Holdings Adr (QX)
16/10/201301h45OTC MarketsReduced neurotoxicity with SPL dendrimer enhanced oxaliplatinUSOTC:SPHRYStarpharma Holdings Adr (QX)
23/09/201307h35OTC MarketsDate of Annual General MeetingUSOTC:SPHRYStarpharma Holdings Adr (QX)
20/09/201301h16OTC MarketsAppendix 3BUSOTC:SPHRYStarpharma Holdings Adr (QX)
16/09/201301h43OTC MarketsStarpharma signs Priostar Agrochemical Partnership with GowanUSOTC:SPHRYStarpharma Holdings Adr (QX)
11/09/201302h06OTC MarketsDendrimer-Oxaliplatin shows better anti-cancer efficacy and less toxicityUSOTC:SPHRYStarpharma Holdings Adr (QX)
26/08/201306h38OTC MarketsAnnual ReportUSOTC:SPHRYStarpharma Holdings Adr (QX)
19/08/201306h05OTC MarketsHome Country News ReleaseUSOTC:SPHRYStarpharma Holdings Adr (QX)
14/08/201306h00OTC MarketsHome Country News Release - Starpharma to present at Canaccord Genuity Annual Growth ConferenceUSOTC:SPHRYStarpharma Holdings Adr (QX)
17/07/201306h00OTC MarketsHome Country News Release - Starpharma appoints Business Development executiveUSOTC:SPHRYStarpharma Holdings Adr (QX)
12/07/201306h00OTC MarketsHome Country News Release - Appendix 3BUSOTC:SPHRYStarpharma Holdings Adr (QX)
11/07/201306h00OTC MarketsHome Country News Release - ARC grant for Starpharma's targeted drug deliveryUSOTC:SPHRYStarpharma Holdings Adr (QX)
19/06/201309h08OTC MarketsNotice of Change in Substantial Holder InterestUSOTC:SPHRYStarpharma Holdings Adr (QX)
11/06/201306h00OTC MarketsHome Country News Release - Starpharma presenting at Nomura Asian Equity ForumUSOTC:SPHRYStarpharma Holdings Adr (QX)
27/05/201306h00OTC MarketsHome Country News Release - Shareholder Update: May 2013USOTC:SPHRYStarpharma Holdings Adr (QX)
22/05/201306h00OTC MarketsHome Country News Release - Corrected Form 604 - Notice of change of interests of substantial holderUSOTC:SPHRYStarpharma Holdings Adr (QX)
21/05/201306h00OTC MarketsHome Country News Release - Starpharma Boardroom Radio InterviewUSOTC:SPHRYStarpharma Holdings Adr (QX)
15/05/201306h00OTC MarketsHome Country News Release - Starpharma presenting at Goldman Sachs Emerging Companies ConferenceUSOTC:SPHRYStarpharma Holdings Adr (QX)
13/05/201306h00OTC MarketsHome Country News Release - Starpharma's dendrimer a potential viral conjunctivitis treatmentUSOTC:SPHRYStarpharma Holdings Adr (QX)
24/04/201301h35OTC MarketsQuarterly ReportUSOTC:SPHRYStarpharma Holdings Adr (QX)
17/04/201306h00OTC MarketsHome Country News Release - Starpharma Granted New Drug Delivery PatentsUSOTC:SPHRYStarpharma Holdings Adr (QX)
08/04/201306h00OTC MarketsHome Country News Release - Change of Director's Interest NoticeUSOTC:SPHRYStarpharma Holdings Adr (QX)
08/04/201306h00OTC MarketsHome Country News Release - Form 604 - Notice of change of interests of substantial holderUSOTC:SPHRYStarpharma Holdings Adr (QX)
03/04/201306h00OTC MarketsHome Country News Release - VivaGel study demonstrates reduced risk of recurrent BVUSOTC:SPHRYStarpharma Holdings Adr (QX)
03/04/201306h00OTC MarketsHome Country News Release - VivaGel phase 2 study results - investor conference callUSOTC:SPHRYStarpharma Holdings Adr (QX)
08/03/201305h01OTC MarketsChange of Director's Interest Notice - Richard HazletonUSOTC:SPHRYStarpharma Holdings Adr (QX)
04/03/201306h00OTC MarketsHome Country News Release - Dendrimers improve anticancer efficacy in lung metastasis modelUSOTC:SPHRYStarpharma Holdings Adr (QX)
14/02/201304h31OTC MarketsSemi-Annual ReportUSOTC:SPHRYStarpharma Holdings Adr (QX)
 Showing the most relevant articles for your search:USOTC:SPHRY

Dernières Valeurs Consultées

EU
RI
Pernod Ricard
EU
DG
Vinci
EU
ML
Michelin
NYSE
MRK
Merck
EU
PX4
SBF 120
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
USI
USTECH100
US Tech 100
EU
SGO
Cie de SaintGobain
EU
PX1
CAC 40
EU
ACA
Credit Agricole
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés